<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>RATIONALE: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a systemic <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e> notable for the development of aortic root <z:hpo ids='HP_0002617'>aneurysms</z:hpo> and the subsequent life-threatening complications of <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> and rupture </plain></SENT>
<SENT sid="1" pm="."><plain>Underlying fibrillin-1 gene mutations cause increased transforming growth factor-β (TGF-β) signaling </plain></SENT>
<SENT sid="2" pm="."><plain>Although TGF-β blockade prevents <z:hpo ids='HP_0002617'>aneurysms</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mouse models, the mechanisms through which excessive TGF-β causes <z:hpo ids='HP_0002617'>aneurysms</z:hpo> remain ill-defined </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: We investigated the role of microRNA-29b (miR-29b) in <z:hpo ids='HP_0002617'>aneurysm</z:hpo> formation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: Using quantitative polymerase chain reaction, we discovered that miR-29b, a microRNA regulating <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and extracellular matrix synthesis/deposition genes, is increased in the ascending aorta of Marfan (Fbn1(C1039G/+)) mice </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0006042'>Increased apoptosis</z:mp>, assessed by increased cleaved caspase-3 and caspase-9, enhanced caspase-3 activity, and decreased levels of the antiapoptotic proteins, Mcl-1 and Bcl-2, were found in the Fbn1(C1039G/+) aorta </plain></SENT>
<SENT sid="6" pm="."><plain>Histological evidence of decreased and fragmented elastin was observed exclusively in the Fbn1(C1039G/+) ascending aorta in association with repressed elastin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and increased matrix metalloproteinase-2 expression and activity, both targets of miR-29b </plain></SENT>
<SENT sid="7" pm="."><plain>Evidence of decreased activation of nuclear factor κB, a repressor of miR-29b, and a factor suppressed by TGF-β, was also observed in Fbn1(C1039G/+) aorta </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, administration of a nuclear factor κB inhibitor increased miR-29b levels, whereas TGF-β blockade or <z:chebi fb="0" ids="6541">losartan</z:chebi> effectively decreased miR-29b levels in Fbn1(C1039G/+) mice </plain></SENT>
<SENT sid="9" pm="."><plain>Finally, miR-29b blockade by <z:chebi fb="0" ids="48010">locked nucleic acid</z:chebi> antisense oligonucleotides prevented early <z:hpo ids='HP_0002617'>aneurysm</z:hpo> development, aortic wall <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and extracellular matrix deficiencies </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: We identify increased miR-29b expression as key to the pathogenesis of early <z:hpo ids='HP_0002617'>aneurysm</z:hpo> development in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> by regulating aortic wall <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and extracellular matrix abnormalities </plain></SENT>
</text></document>